Comunicati.net - Comunicati pubblicati - sravan Comunicati.net - Comunicati pubblicati - sravan Sat, 26 May 2018 12:07:23 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/utenti/24023/1 Global Uveal Melanoma Therapeutics Market: Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024 Fri, 25 May 2018 12:51:52 +0200 http://comunicati.net/comunicati/turismo/manifestazioni/480694.html http://comunicati.net/comunicati/turismo/manifestazioni/480694.html sravan sravan Global Uveal Melanoma Therapeutics Market: Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Uveal Melanoma Therapeutics Market: By Disease Type (Choroidal Melanomas, Iris Melanomas, and Ciliary Body Melanomas), By Treatment Type (Chemotherapy, Immunotherapy, and Targeted Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global uveal melanoma therapeutics market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Uveal Melanoma Therapeutics Market

Uveal melanoma is a disease in which malignant (cancer) cells form in the tissues of the eye. The tumors arise from the melanocytes that reside within the uvea giving color to the eye. Uveal melanoma begins between the three layers of the wall of the eye. The first layer (outer layer) includes sclera and the cornea at the front of the eye. The inner layer has a retina, that senses light and send images. The middle layer is the layer in which the melanoma forms. This layer is called as uvea.

Increase in the prevalence of uveal melanoma is driving the growth of the market. The rising awareness among the people regarding the disease among healthcare fraternity is anticipated to drive the growth of the uveal melanoma therapeutics market. However, the higher cost of the therapy and reimbursement policies are may constrain the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Uveal Melanoma Therapeutics Market

Uveal melanoma therapeutics market is segmented based on the disease type, treatment type, and distribution channel.

Based on the disease type, the market is segmented into the following:

·         Choroidal Melanomas

o   Small Melanomas

o   Medium-sized Melanomas

o   Large Melanomas

·         Iris melanomas

·         Ciliary Body Melanomas

Based on the treatment type, the market is segmented into the following:

·         Chemotherapy

o   Methotrexate

o   Others

·         Immunotherapy Drugs

o   Pembrolizumab

o   Ipilimumab

o   Others

·         Targeted Drugs

Based on the distribution channel, the market is segmented into the following:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Uveal Melanoma Therapeutics Market

Geographically, global uveal melanoma therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America uveal melanoma therapeutics market is driven by increase in the prevalence of the eye related disorders. The growing patient population with uveal melanoma disorder expected fuel the market growth in the region. According to the American Cancer Society, about nine of 10 melanomas of the eye develop in the choroid. It also states that 2,730 new cases were detected in 2014 of uveal melanoma in the U.S.

 

Competition Assessment: Uveal Melanoma Therapeutics Market

Some of the players in the global uveal melanoma therapeutics market include:

·         Eli Lilly & Co. (U.S)

·         Novartis AG (Switzerland)

·         AstraZeneca plc (UK)

·         Pfizer, Inc. (U.S)

·         Merck (U.S)

·         Roche (Switzerland)

·         Amgen (U.S)

·         Bayer (Germany)

·         Spectrum Pharmaceuticals, Inc. (U.S)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Uveal Melanoma Therapeutics Market

Ø  Bristol-Myers Squibb and National Cancer Institute (NCI) completed the phase II  study of Nivolumab in combination with Ipilimumab for Uveal Melanoma

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Tissue Engineered Collagen Biomaterials Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024 Fri, 25 May 2018 12:51:39 +0200 http://comunicati.net/comunicati/societa_civile/partiti/radicali/480693.html http://comunicati.net/comunicati/societa_civile/partiti/radicali/480693.html sravan sravan Tissue Engineered Collagen Biomaterials Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Tissue Engineered Collagen Biomaterials Market: By Source (Marine, Bovine, Chicken, Porcine, and Others), By Application (Wound Care, Orthopedic, and Others), By Distribution Channel (Hospitals, Orthopedic Clinics, and Others), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global tissue Engineered collagen biomaterials market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Tissue Engineered Collagen Biomaterials Market

Collagen is the class of protein that is widely distributed in the human body. The collagen-based biomaterials has been used intensively in the tissue engineering applications. There are various methods such as multiple-cross linking and several combinations of biopolymers are being investigated, which further helps in improving the tissue function.

Increase in the use of collagen as the bone substitutes is the key factor attributed for the growth of the market. The growing initial investments in the research and development activities and rising use of the collagen in the wound healing process is enhancing the growth of the market. However, stringent government regulations are likely to hamper the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Tissue Engineered Collagen Biomaterials Market

Tissue Engineered collagen biomaterials market is segmented based on the source, applications, and distribution channel

Based on the source, the market is segmented into the following:

·         Marine

·         Bovine

·         Chicken

·         Porcine

·         Others

Based on the application, the market is segmented into the following:

·         Wound Care

·         Orthopedic

·         Others

Based on the distribution channel, the market is segmented into the following:

·         Hospitals

·         Orthopedic Clinics

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Tissue Engineered Collagen Biomaterials Market

Geographically, global tissue engineered collagen biomaterials market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America tissue Engineered collagen biomaterials market holds dominant share when compared with that of the other regional markets. The soaring use of the collagen in numerous orthopedic applications is anticipated to drive the growth of the market in the region. The European region and the Asia Pacific follow the suit. The Asia Pacific is expected to show significant growth over the forecast period owing to its burgeoning ageing population. The increasing prevalence of chronic diseases is another factor attributed for the growth of the market in the region. 

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Tissue Engineered Collagen Biomaterials Market

Some of the players in the global tissue Engineered collagen biomaterials market include:

·         Medtronic (U.S)

·         Collagen Solutions Plc (UK)

·         Kyeron B.V (The Netherlands)

·         Collagen Matrix Inc (U.S)

·         Fraunhofer-Gesellschaft (Germany)

·         Maxigen Biotech Inc (Taiwan)

·         Advanced BioMatrix Inc (U.S)

 

Notable Market Developments: Tissue Engineered Collagen Biomaterials Market

Ø  In July 2017, Collagen Solutions plc has announced its first patient enrolment in ChondroMimetic long-term clinical study.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Global Thrombocytopenia Treatment Market: Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024 Fri, 25 May 2018 12:46:49 +0200 http://comunicati.net/comunicati/sport/ginnastica/480692.html http://comunicati.net/comunicati/sport/ginnastica/480692.html sravan sravan Global Thrombocytopenia Treatment Market: Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Thrombocytopenia Treatment Market: By Drug Class (Lysosomal Enzyme, Platelet Stimulating Agents, and Glucocorticoids), By Disease Indication (Leukemia, Hemolytic Uremic Syndrome, Immune Thrombocytopenia, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global thrombocytopenia treatment market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Thrombocytopenia Treatment Market

Thrombocytopenia is the condition where in which the patient has a low platelet count. The root cause for the thrombocytopenia are the platelet splenic sequestration, inefficiency in the production of the platelets and the destruction of the platelets. Thrombocytopenia is either inherited or acquired. It usually occurs owing to various disorders such as leukemia and immune system related conditions. This is commonly found in both adults and children. In thrombocytopenia condition show very less symptoms and is mild. In some cases, the count of the platelets is so low that it causes dangerous internal bleeding, as the patient affected with the thrombocytopenia leads to delayed blood clotting or sometimes no blood clotting.

 

Market Dynamics: Thrombocytopenia Treatment Market

Increase in the prevalence of thrombocytopenia all across the globe and rising count of the chronic hepatitis C cases, which causes the risk of thrombocytopenia are likely to drive the growth of the market. The growing government support by financial aids to the patients in developing and under developed countries expected to drive the market revenue growth over forecast period. However, the stringent government regulations for approvals of newer treatments and increasing introduction of the generic drugs may hinder the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Thrombocytopenia Treatment Market

Thrombocytopenia treatment market is segmented based on the drug class, disease indication, and distribution channel

 

Based on the drug class, the market is segmented into the following:

·         Lysosomal Enzyme

·         Platelet Stimulating Agent

·         Glucocorticoids

Based on the disease indication, the market is segmented into the following:

·         Leukemia

·         Hemolytic Uremic Syndrome

·         Immune Thrombocytopenia

·         Others

Based on the distribution channel, the market is segmented into the following:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Thrombocytopenia Treatment Market

Geographically, global thrombocytopenia treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America thrombocytopenia treatment market is growing due to increase in the prevalence of thrombocytopenia. The deep-rooted healthcare infrastructure is also anticipated to drive the growth of the market in the region. The awareness among the patient population regarding the new treatment methods is likely to enhance the growth of the market in the region. The adoption of the new treatment procedures by the patient pool is boosting the growth of the thrombocytopenia treatment market in the region.

 

Competition Assessment: Thrombocytopenia Treatment Market

Some of the players in the global thrombocytopenia treatment market include:

·         Merck & Co., Inc. (U.S)

·         Bristol-Myers Squibb Company (U.S)

·         ViroMed Co., Ltd (South Korea)

·         Rigel Pharmaceuticals, Inc. (U.S)

·         Shionogi & Co., Ltd. (Japan)

·         Cellerant Therapeutics, Inc. (U.S)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Thrombocytopenia Treatment Market

Ø  In February 2018, Shionogi & Co., Ltd announced that the New Drug Application (NDA) for lusutrombopag (S-888711), an investigational, once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, has been accepted for filing and has been granted Priority Review by the U.S. Food & Drug Administration (FDA)

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Global Surgical Sutures Market: Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024 Fri, 25 May 2018 12:46:29 +0200 http://comunicati.net/comunicati/arte/musica/new_age/480691.html http://comunicati.net/comunicati/arte/musica/new_age/480691.html sravan sravan Global Surgical Sutures Market: Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Surgical Sutures Market: By Product Type (Absorbable and Non-absorbable), By Material (Monofilament Suture and Multifilament Suture), By Application (Gynecological Surgeries, Orthopedic Surgeries, Cardiovascular Surgeries, General Surgeries, Ophthalmic Surgeries, and Other Surgeries), By End User (Hospitals, Clinics, and Others), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global surgical sutures market was valued at US$ XX Mn in 2017 and expected to grow at 5.3% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Surgical Sutures Market

Surgical sutures are the medical devices that are used to hold body tissues together post-surgery or injury. They are usually classified into absorbable surgical sutures and non-absorbable surgical sutures. The absorbable surgical suture will break down harmlessly in the body over time without intervention. While the non-absorbable surgical sutures must be manually removed. Sutures can also be divided basing of material structure i.e. monofilament sutures and multifilament or braided sutures. Monofilament sutures elicit lower tissue reaction compared to braided sutures. Multifilament sutures are braided and often coated with various materials like silicon, wax, PTFE, polycaprolactone, calcium stearate etc.

 

Market Dynamics: Surgical Sutures Market

Increasing incidence of traffic accidents is the key factor attributing the growth of the surgical sutures market. The use of the surgical sutures is more in the treatment of the accidents. According to World Health Organization (WHO) in 2017, yearly around 1.25 million people die and more than 20 to 50 million people experience severe injuries, due to road traffic crash. The increasing use of the surgical sutures in multiple treatments and growing trend of cosmetic surgeries are anticipated to drive the market growth of the surgical sutures. As per the annual plastic surgery procedural statistics by American Society of Plastic Surgeons (ASPS), there were 15.9 million surgical and minimally-invasive cosmetic procedures performed in the United States in 2015, 2.0% increase over 2014. The growing geriatric population along with growing organ transplantation and cardiovascular surgeries is boosting the growth of the surgical sutures market. However, the growth of the product development is at a slow pace, which is likely to hamper the growth of the surgical sutures market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/surgical-sutures-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Surgical Sutures Market

Surgical sutures market is segmented based on the product type, material, application, and end user

Based on the product type, the market is segmented into the following:

·         Absorbable

o   Natural Sutures

o   Synthetic Sutures

§  Vicryl Sutures

§  Monocryl Sutures

§  Polydioxanone Sutures

§  Polyglycolic Sutures

§  Others

·         Non-absorbable

o   Nylon Sutures

o   Prolene Sutures

o   Stainless Steel Sutures

o   Others

Based on the material, the market is segmented into the following:

·         Monofilament Suture

·         Multifilament Suture

Based on the application, the market is segmented into the following:

·         Gynecological Surgeries

·         Orthopedic Surgeries

·         Cardiovascular Surgeries

·         General Surgeries

·         Ophthalmic Surgeries

·         Other Surgeries

Based on the end user, the market is segmented into the following:

·         Hospitals

·         Clinics

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/surgical-sutures-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Surgical Sutures Market

Geographically, global surgical sutures market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America surgical sutures market is the dominant market owing increase in the number of surgeries. Rising number of private sector hospitals and developing healthcare infrastructure is anticipated to drive the growth of the surgical sutures market in the region. Europe surgical sutures market is falling next to that of North America. The Asia Pacific surgical sutures market is expected to grow at significant rate over the forecast period owing to the increasing surgical cases and growing trend of plastic surgery.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/surgical-sutures-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Surgical Sutures Market

Some of the players in the global surgical sutures market include:

·         Boston Scientific Corporation (U.S)

·         Medtronic plc (Ireland)

·         Internacional Farmaceutica, S.A. de C.V. (Mexico)

·         Sutures India Pvt. Ltd. (India)

·         Péters Surgical (France)

·         Smith & Nephew plc (U.K.)

·         EndoEvolution, LLC (U.S.)

·         Ethicon Inc. (U.S.)

·         B. Braun Melsungen AG (Germany)

·         DemeTECH Corporation (U.S.)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/surgical-sutures-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Global Phototherapy Equipment Market - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024 Fri, 25 May 2018 12:46:14 +0200 http://comunicati.net/comunicati/societa_civile/partiti/alleanza_nazionale/480690.html http://comunicati.net/comunicati/societa_civile/partiti/alleanza_nazionale/480690.html sravan sravan Global Phototherapy Equipment Market - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Phototherapy Equipment Market: By Device Type (Fluorescent Lamps, Compact Fluorescent Lamps, Fiberoptic Phototherapy Equipment, LED Phototherapy Equipment, and Conventional Phototherapy Equipment), By Application (Neonatal Jaundice and Skin Diseases), By End User (Hospitals, Clinics, and Others), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global phototherapy equipment market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

Market Outline: Phototherapy Equipment Market

Phototherapy or light therapy involves exposing the skin to ultraviolet light on a regular basis and under medical supervision. The UV part of the radiation emitted by the sun that is used in phototherapy, especially the ultraviolet B (UVB) and ultraviolet A (UVA) wavelengths. Using phototherapy, exposure of specific wavelengths of light using polychromatic polarized light, fluorescent lamps, and lasers is used for the treatment.

Market Dynamics: Phototherapy Equipment Market

Increase in the prevalence of neonatal jaundice and growing number of the preterm birth are the key factors attributed for the growth of the phototherapy equipment market. According to the National Center for Biotechnology Information (NCBI), around 13 million babies are affected with jaundice all across the globe. The increasing incidence of the psoriasis is aiding the growth of the phototherapy equipment market. According to the International Federation of Psoriasis Associations (IFPA), around 150,000 new cases are reported in the U.S every year and 3% of people are affected by some form of psoriasis around the world. The treatment of these skin disorders requires phototherapy, which is expected to boost the growth of the market. However, the high cost of the equipment may hinder the growth of the phototherapy equipment market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Phototherapy Equipment Market

Phototherapy equipment market is segmented based on the device type, application, and distribution channel

Based on the device type, the market is segmented into the following:

·         Fluorescent Lamps

·         Compact Fluorescent Lamps

·         Fiberoptic Phototherapy Equipment

·         LED Phototherapy Equipment

·         Conventional Phototherapy Equipment

Based on the application, the market is segmented into the following:

·         Neonatal Jaundice

·         Skin Diseases

o   Psoriasis

o   Eczema

o   Other skin diseases

·         Others

Based on the distribution channel, the market is segmented into the following:

·         Hospitals

·         Clinics

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Phototherapy Equipment Market

Geographically, global phototherapy equipment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America phototherapy equipment market to keep top spot in the global phototherapy equipment market. The rising awareness among the people regarding the modern treatment procedures for treating skin-related disorders is enhancing the growth of the phototherapy equipment market. For instance, according to the American Academy of Dermatology acne is the most common skin condition in the U.S., affecting around 50 million people in the country each year. Europe and Asia Pacific phototherapy equipment market is expected to grow exponentially over the forecast period.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Phototherapy Equipment Market

Some of the players in the global phototherapy equipment market include:

·         Atom Medical Corporation (Japan)

·         National Biological Corp. (U.S.)

·         Solarc Systems Inc. (Canada)

·         GE Healthcare (U.K.)

·         Philips Lighting Holding B.V. (Netherlands

·         Natus Medical Incorporated (U.S.)

·         Phoenix Medical Systems Pvt. Ltd. (India)

·         Herbert Waldmann GmbH & Co. KG (Germany)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Global Dermal Fillers Market was Valued at US$ 3.2 Bn in 2017 Thu, 24 May 2018 14:21:25 +0200 http://comunicati.net/comunicati/turismo/last_minute/480536.html http://comunicati.net/comunicati/turismo/last_minute/480536.html sravan sravan The Global Dermal Fillers Market was valued around US$ 3.2 Bn by 2017 and growing at a significant CAGR over six years forecast period 2018-2023 owing to increase in the incidence of cosmetic skin issues and awareness among young population

 

Precision Business Insights (PBI) in its report titled “Global Dermal Fillers Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023” assesses the market performance over forecast period (2018-2023). The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

 

The global dermal fillers market was valued at US$ 3.2 Bn in 2017 and growing at a significant CAGR over the forecast period owing to increase in the number patients with different cosmetic skin issues like deep lines, wrinkles and scars around the globe. Additionally, rise in number of geriatric population, rise in preference for minimally invasive or non-invasive surgical procedures, and fast and ease of treatment are anticipated to propel the global dermal fillers market. However, high cost for the dermal fillers procedure and post-procedure complications are expected to hinder the growth of global dermal fillers market over forecast years.

 

Global dermal fillers market segmented on the basis of product type, ingredient type, distribution channel, and region

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-4H8Z4LpNMLEuOnnx

 

Absorbable dermal fillers accounted for higher revenue share

 

Based on product type, global dermal fillers market segmented into absorbable dermal fillers and non-absorbable dermal fillers. Absorbable dermal fillers market accounted for larger revenue share in 2017 and projected to dominate over the forecast period owing to growing adoption by patients and its safety profile. Moreover, absorbable dermal fillers segment projected exhibit lucrative growth, which is mainly attributed to non-invasive or minimally invasive treatment procedure and low cost of the treatment.

North America leads the Global Dermal Fillers market

 

PBI’s global dermal fillers market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2012-2017 and the same trend is projected to follow over 2018-2023 owing to increase in the preference for non-invasive aesthetic procedures, rise in geriatric population, and increase in disposable income.

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-c654SbFYO64MsOhu

 

Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

 

Global dermal fillers market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. In 2015, Allergan plc, received approval from the U.S.FDA approval to market its juvederm ultra XC injection used for lip augmentation in adults over the age of 21

 

Key player’s profiles in the report are Galderma (Nestle) (Switzerland), MERZ PHARMA GMBH & CO. KGAA (Germany), and Allergan plc (Ireland)

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-14mlyhjMGhVjZqa3

 

Detailed Segmentation

 

By Product Type

o   Absorbable Dermal Fillers

o   Non-Absorbable Dermal Fillers

By Ingredient Type

o   Hyaluronic Acid (HLA)

o   Poly-L-Lactic Acid (PLA)

o   Calcium Hydroxylapatite (CaH)

o   Polymethylmethacrylate (PMMA)

o   Collagen

o   Others

By Distribution Channel

o   Retail Pharmacies

o   Beauty Clinics

o   Online Pharmacies

Geography

 

o     North America

·         U.S

·         Canada

o     Europe

·         Germany

·         France

·         U.K

·         Italy

·         Spain

·         Russia

·         Poland

·         Rest of Europe

o     Asia-Pacific

·         Japan

·         China

·         India

·         Australia & New Zealand

·         ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)

·         South Korea

·         Rest of Asia-Pacific

o     Latin America

·         Brazil

·         Mexico

·         Argentina

·         Venezuela

·         Rest of Latin America

o     Middle East and Africa (MEA)

·         Gulf Cooperation Council (GCC) Countries

·         Israel

·         South Africa

·         Rest of MEA

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Traumatic Brain Injury Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 09:16:02 +0200 http://comunicati.net/comunicati/sport/volo/480476.html http://comunicati.net/comunicati/sport/volo/480476.html sravan sravan Traumatic Brain Injury Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Traumatic Brain Injury Treatment Market: By Treatment Type (Drugs, Surgery), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global traumatic brain injury treatment market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Traumatic Brain Injury Treatment Market

Traumatic brain injury (TBI) or intracranial injury is an injury to brain due to external force to brain. TBI can be classified as mild, moderate, and severe brain injury. TBI may be occur due to falls, vehicle collision, and violence. Symptoms of traumatic brain injury include cognitive, physical, social, and behavioural symptoms and outcome can range from complete recovery to permanent disability and may causes death. TBI can be diagnosed by using computed tomography (CT) and magnetic resonance imaging (MRIs).

 

Market Dynamics: Traumatic Brain Injury Treatment Market

Increase in the prevalence of brain traumatic injuries due to rise in number of road accidents and falls is expected to drives the global traumatic brain injuries market over the forecast period. Moreover, rise in number of geriatric population, increase in the R & D for innovation of newer products, promising pipeline products for TBIs, and entry of targeted therapies into the market are expected to boost the global traumatic brain injuries market. However, delayed disease diagnosis, lack of social awareness, and lack of government support for R&D activities are anticipated to restrain the growth of traumatic brain injuries market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/traumatic-brain-injury-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Traumatic Brain Injury Treatment Market

Traumatic brain injury treatment market is segmented on the basis of treatment type, route of administration, and distribution channel

Based on the treatment type, traumatic brain injuries treatment market is segmented into the following:

·         Drugs

·         Analgesics

·         Anti-Convulsants

·         Anti-Anxiety Drugs

·         Anti-Psychotics

·         Anti-Depressants

·         Anti-Coagulants

·         Others

·         Surgery

Based on the route of administration, traumatic brain injuries treatment market is segmented into the following:

·         Oral

·         Parenteral

Based on the distribution channel, traumatic brain injuries treatment market is segmented into the following:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Stores

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/traumatic-brain-injury-treatment-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Traumatic Brain Injury Treatment Market

Geographically, global traumatic brain injuries treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America traumatic brain injuries treatment market is led by U.S., due to increase in the prevalence of TBIs (According to CDC 2010, approximately 2.5 Mn people are admitted in hospital with TBI and about 138 people die in U.S. with TBIs). Surge in R&D expenditure for the development of newer drugs, and presence of skilled professionals for TBI surgeries are expected to propel the market. Europe traumatic brain injuries treatment market is expected to grow due to adoption of newer techniques for early stage disease diagnosis, promising product pipeline, and increase in the prevalence of TBIs are expected to boost the market. Asia pacific traumatic brain injuries treatment market has significant growth attributed to increase in medical tourism in Asia Pacific region due to low cost of treatment, entry of market players into Asia Pacific, and large patient pool are expected to bolster the market over the forecast years.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/traumatic-brain-injury-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Traumatic Brain Injury Treatment Market

Some of the players in the global traumatic brain injury treatment market include:

·         TEVA Pharmaceutical Industries Ltd. (Israel)

·         Tenax Therapeutics (U.S.)

·         Amarantus BioScience Holdings (U.S.)

·         Neuren Pharmaceuticals Ltd (Australia)

·         Grace Laboratories LLC. (Georgia)

·         Banyan Biomarkers Inc. (U.S)

·         Vasopharm GmbH

·         Cognosci, Inc. (U.S.)

·         Medicortex Finland Oy (Finland)

 

 

Notable Market Developments: Traumatic Brain Injury Treatment Market

·         In May 2016, Stemedica Cell Technologies, Inc. received FDA investigational new drug (IND) approval for mesenchymal stem cells to treat traumatic brain injury

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/traumatic-brain-injury-treatment-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Smart Pills Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 09:15:50 +0200 http://comunicati.net/comunicati/turismo/manifestazioni/480475.html http://comunicati.net/comunicati/turismo/manifestazioni/480475.html sravan sravan Smart Pills Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Smart Pills Market: By Application (Drug Delivery, Capsule Endoscopy, Patient Monitoring), By Target Area (Stomach, Esophagus, Large Intestine, Small Intestine), By End User (Hospitals, Clinics, Research Institutes), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global smart pills market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

Market Outline: Smart Pills Market

 

Smart pills are the injectable medical devices taken orally to examine gastrointestinal tract. The advanced smart pills enable disease diagnosis, patient monitoring, and help to improve the drug delivery. Cameras, trackers, and sensors are commonly used smart pills swallowed by patient to get complete GI evaluation without surgery. Smart pills expected to replace the conventional diagnostic techniques such as colonoscopy and endoscopy.

 

Market Dynamics: Smart Pills Market

Increase in geriatric population coupled with rise in preference for minimally invasive surgical procedures are anticipated to drive the global smart pills market. Moreover, technological advancements of the smart pills, rise in prevalence of GI disorders, sophisticated healthcare infrastructure, wide applications with smart pills, and rise in disposable income are anticipated to fuel the global smart pills market over the forecast period. However, high cost of products, technological constraints the efficiency of capsule endoscopes, and patients fear regarding the smart pill swallowing are expected to dampen the growth of smart pills market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/smart-pills-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Smart Pills Market

Smart Pills market is segmented based on the application, target area, and end user

Based on the application, the market is segmented into the following:

·         Drug Delivery

·         Capsule Endoscopy

·         Patient Monitoring

Based on the target area, the market is segmented into the following

·         Stomach

·         Esophagus

·         Large Intestine

·         Small Intestine

Based on the distribution channel, the market is segmented into the following:

·         Hospitals

·         Clinics

·         Research Institutes

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/smart-pills-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Smart Pills Market

Geographically, global smart pills market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America smart pills market has a lucrative share attributed to increase in the prevalence of GI disorders due to change in lifestyle, innovation of newer smart pills by market players, and favorable reimbursement policies are fuel the market. Europe smart pills market is poised to grow at a notable CAGR due to adoption of technologically advanced smart pills, rise in government investment in healthcare sector, and well established healthcare infrastructure. Asia Pacific smart pills market has a lucrative growth owing to large patient pool with GI disorders, increase in healthcare expenditure, and entry of market players into Asia Pacific region are fuel the market.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/smart-pills-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Smart Pills Market

Some of the players in the global smart pills market include:

·         Medimetrics S.A. de C.V. (Mexico)

·         CapsoVision, Inc. (U.S.)

·         Bio-Images Research Limited (U.K.)

·         Olympus Corporation (Japan)

·         Given Imaging, Inc. (Israel)

·         SmartPill Corporation (U.S.)

·         Siemens Healthineers (U.S.)

·         Medtronic plc (Ireland)

·         Koninklijke Philips N.V. (Netherlands)

·         GE Healthcare (U.S.)

·         Otsuka America Pharmaceutical, Inc. (U.S.)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/smart-pills-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Smart Pills Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 09:15:47 +0200 http://comunicati.net/comunicati/turismo/manifestazioni/480474.html http://comunicati.net/comunicati/turismo/manifestazioni/480474.html sravan sravan Smart Pills Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Smart Pills Market: By Application (Drug Delivery, Capsule Endoscopy, Patient Monitoring), By Target Area (Stomach, Esophagus, Large Intestine, Small Intestine), By End User (Hospitals, Clinics, Research Institutes), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global smart pills market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

Market Outline: Smart Pills Market

 

Smart pills are the injectable medical devices taken orally to examine gastrointestinal tract. The advanced smart pills enable disease diagnosis, patient monitoring, and help to improve the drug delivery. Cameras, trackers, and sensors are commonly used smart pills swallowed by patient to get complete GI evaluation without surgery. Smart pills expected to replace the conventional diagnostic techniques such as colonoscopy and endoscopy.

 

Market Dynamics: Smart Pills Market

Increase in geriatric population coupled with rise in preference for minimally invasive surgical procedures are anticipated to drive the global smart pills market. Moreover, technological advancements of the smart pills, rise in prevalence of GI disorders, sophisticated healthcare infrastructure, wide applications with smart pills, and rise in disposable income are anticipated to fuel the global smart pills market over the forecast period. However, high cost of products, technological constraints the efficiency of capsule endoscopes, and patients fear regarding the smart pill swallowing are expected to dampen the growth of smart pills market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/smart-pills-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Smart Pills Market

Smart Pills market is segmented based on the application, target area, and end user

Based on the application, the market is segmented into the following:

·         Drug Delivery

·         Capsule Endoscopy

·         Patient Monitoring

Based on the target area, the market is segmented into the following

·         Stomach

·         Esophagus

·         Large Intestine

·         Small Intestine

Based on the distribution channel, the market is segmented into the following:

·         Hospitals

·         Clinics

·         Research Institutes

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/smart-pills-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Smart Pills Market

Geographically, global smart pills market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America smart pills market has a lucrative share attributed to increase in the prevalence of GI disorders due to change in lifestyle, innovation of newer smart pills by market players, and favorable reimbursement policies are fuel the market. Europe smart pills market is poised to grow at a notable CAGR due to adoption of technologically advanced smart pills, rise in government investment in healthcare sector, and well established healthcare infrastructure. Asia Pacific smart pills market has a lucrative growth owing to large patient pool with GI disorders, increase in healthcare expenditure, and entry of market players into Asia Pacific region are fuel the market.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/smart-pills-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Smart Pills Market

Some of the players in the global smart pills market include:

·         Medimetrics S.A. de C.V. (Mexico)

·         CapsoVision, Inc. (U.S.)

·         Bio-Images Research Limited (U.K.)

·         Olympus Corporation (Japan)

·         Given Imaging, Inc. (Israel)

·         SmartPill Corporation (U.S.)

·         Siemens Healthineers (U.S.)

·         Medtronic plc (Ireland)

·         Koninklijke Philips N.V. (Netherlands)

·         GE Healthcare (U.S.)

·         Otsuka America Pharmaceutical, Inc. (U.S.)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/smart-pills-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Platelet Rich Plasma (PRP) Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 09:15:33 +0200 http://comunicati.net/comunicati/societa_civile/partiti/democratici_di_sinistra/480473.html http://comunicati.net/comunicati/societa_civile/partiti/democratici_di_sinistra/480473.html sravan sravan Platelet Rich Plasma (PRP) Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Platelet Rich Plasma (PRP) Market: By Product Type (Pure Platelet Rich Plasma, Pure Platelet Rich Fibrin, Leukocyte-Platelet Rich Fibrin, Others), By Application (General Surgery, Neurosurgery, Cardiac Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global platelet rich plasma (PRP) market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.

 

Market Outline: Global Platelet Rich Plasma (PRP) Market

Platelet rich plasma (PRP) is a permanent solution for various conditions such as ligament/tendon sprains, arthritis, and tears. Platelet rich plasma (PRP) therapy is usually done by utilizing the body’s natural healing process. In this therapy, the concentration of platelets are injected into the damaged tendons, joints and ligaments in order to accelerate healing that anticipates tissue repair. The platelets are considered to be rich in growth and healing factors. The Platelet rich plasma (PRP) injections are used in the treatment of various conditions such as shoulder pain and instability, lumbar spine disc pain, knee sprains and instability, hamstring and hip strains, ankle sprains, knee, hip, and other joint osteoarthritis among others.

 

Market Dynamics: Global Platelet Rich Plasma (PRP) Market

Increase in the geriatric population along with increase in health issues are the key factors attributing the growth of Platelet rich plasma (PRP) market. The rising applications of platelet rich plasma (PRP) in various areas anticipated to fuel the growth of the market. The soaring use of PRP application in the cosmetic surgeries is boosting the growth of the market. The successful application of PRP in the orthopedic disorders such as Achilles tendinopathy, knee osteoarthritis, rotator cuff tears, and lateral epicondylitis has enhanced the growth of the Platelet rich plasma market. Growing incidence of sport injuries is adding scope for further growth in the market. However, the high risk of contamination owing to improper storage is hampering the growth of the market. The difficulty in quality control of test results is hindering the growth of the Platelet rich plasma market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/platelet-rich-plasma-prp-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Global Platelet Rich Plasma (PRP) Market

Platelet rich plasma (PRP) market is segmented on the basis of product type, application, and end user

Based on the product type, the market is segmented into the following:

·         Pure Platelet Rich Plasma

·         Pure Platelet Rich Fibrin

·         Leukocyte-Platelet Rich Fibrin

·         Others

Based on the application, the market is segmented into the following:

·         General Surgery

·         Neurosurgery

·         Cardiac Surgery

·         Orthopedic Surgery

·         Others

Based on the end user, the market is segmented into the following:

·         Hospitals

·         Ambulatory Surgical Centers (ASCs)

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/platelet-rich-plasma-prp-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis: Global Platelet Rich Plasma (PRP) Market

Geographically, global platelet rich plasma (PRP) market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America platelet rich plasma (PRP) market is set to expand at significant CAGR owing to increase in the number of surgeries due to rise in prevalence of cardiac and neurodegenerative disorders, advancements in healthcare technology, and presence of significant market players in the North America. Europe platelet rich plasma (PRP) market has lucrative growth attributed to increase in demand for cosmetic surgeries, increase in the number of sports injuries, and rise in focus on R&D to develop the newer products are anticipated to propel the market. However, Asia Pacific platelet rich plasma (PRP) market is poised to grow due to entry of market players into Asia Pacific countries, increase in the number of surgical procedures due to rise in medical tourism, and grow in geriatric population in India and China are surge the market

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/platelet-rich-plasma-prp-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Global Platelet Rich Plasma (PRP) Market

Some of the players in the global platelet rich plasma (PRP) market include:

·         Bio Products Laboratory Ltd. (BPL) (UK)

·         Cambryn Biologics LLC (U.S.)

·         CSL Ltd. (Australia)

·         Kedrion S.p.A. (Italy)

·         China Biologic Products, Inc. (China)

·         LFB S.A. (France)

·         Grifols International S.A. (Spain)

·         Octapharma (Switzerland)

·         BioLife Plasma Services (U.S.)

·         Biotest (Germany)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/platelet-rich-plasma-prp-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Oral Contraceptive Pills Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 09:15:17 +0200 http://comunicati.net/comunicati/turismo/localita/milano_marittima/480472.html http://comunicati.net/comunicati/turismo/localita/milano_marittima/480472.html sravan sravan Oral Contraceptive Pills Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Oral Contraceptive Pills Market: By Drug Type (Progestin Only Pills, Combination Pills, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global oral contraceptive pills market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Oral Contraceptive Pills Market

Oral contraceptive pills or birth control pills are the medications used to prevent the pregnancy. These are hormonal preparations that contain combination of hormones estrogen and progestin or progestin alone. The mechanism of action of oral contraceptive pills is prevent the pregnancy by inhibiting the follicle stimulating hormone (FSH) and Luteinizing hormone (LH) which play a major roles in egg development and preparation of lining of uterus for implantation of embryo.

 

Market Dynamics: Oral Contraceptive Pills Market

Increase in the incidence of unwanted pregnancies is anticipated to drive the global oral contraceptive pills market. Moreover, rise in female population, low cost of oral contraceptive pills, ease of administration, adoption of novel oral contraceptive pills in developed and developing countries, and high effectiveness of the pills are anticipated to propel the global oral contraceptives market. However, stringent regulatory guidelines for the oral contraceptive pills usage, adverse effects associated with the products, religious issues, and poor availability of the products in underdeveloped regions are major restrains of global oral contraceptive pills market over the forecast years.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/oral-contraceptive-pills-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Oral Contraceptive Pills Market

Oral Contraceptive Pills market is segmented based on the drug type, and distribution channel

Based on the drug type, the market is segmented into the following:

·         Progestin Only Pills

·         Combination Pills

·         Monophasic

·         Triphasic

·         Others

·         Others

Based on the distribution channel, the market is segmented into the following:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/oral-contraceptive-pills-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Oral Contraceptive Pills Market

Geographically, global oral contraceptive pills market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America oral contraceptive pills markethas a lucrative share attributed to high incidence rate of unwanted pregnancies, government support to opt for modern oral contraceptive pills and rise in disposable income. Europe oral contraceptive pills market is poised to grow due to expansion of business by the market players in EU region, grow in women workforce preferring to postpone the pregnancies, and better availability of the products are expected to bolster the market. Asia Pacific oral contraceptive pills market has a lucrative growth attributed to surge in awareness about the family planning and oral contraceptive pills, rise in disposable income, and increase in people opting for right decisions about their sexual and reproductive health are enhance the revenue of market.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/oral-contraceptive-pills-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Oral Contraceptive Pills Market

Some of the players in the global oral contraceptive pills market include:

·         Actavis plc (Allergan plc) (Ireland)

·         Bayer AG (Germany)

·         Merck & Co. Inc. (U.S.)

·         Pfizer, Inc. (U.S.)

·         Teva Pharmaceutical Industries Ltd (Israel)

·         Church & Dwight Co, Inc. (U.S)

·         Mylan N.V. (U.S.)

·         Novartis AG (Switzerland)

·         Piramal Enterprises Limited (India)

Notable Market Developments: Oral Contraceptive Pills Market

·         In April 2018, Mylan N.V. launched Drospirenone and Ethinyl Estradiol tablets in U.S. used as oral contraceptive pills.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/oral-contraceptive-pills-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Oral Contraceptive Pills Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 09:15:15 +0200 http://comunicati.net/comunicati/turismo/localita/milano_marittima/480471.html http://comunicati.net/comunicati/turismo/localita/milano_marittima/480471.html sravan sravan Oral Contraceptive Pills Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Oral Contraceptive Pills Market: By Drug Type (Progestin Only Pills, Combination Pills, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global oral contraceptive pills market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Oral Contraceptive Pills Market

Oral contraceptive pills or birth control pills are the medications used to prevent the pregnancy. These are hormonal preparations that contain combination of hormones estrogen and progestin or progestin alone. The mechanism of action of oral contraceptive pills is prevent the pregnancy by inhibiting the follicle stimulating hormone (FSH) and Luteinizing hormone (LH) which play a major roles in egg development and preparation of lining of uterus for implantation of embryo.

 

Market Dynamics: Oral Contraceptive Pills Market

Increase in the incidence of unwanted pregnancies is anticipated to drive the global oral contraceptive pills market. Moreover, rise in female population, low cost of oral contraceptive pills, ease of administration, adoption of novel oral contraceptive pills in developed and developing countries, and high effectiveness of the pills are anticipated to propel the global oral contraceptives market. However, stringent regulatory guidelines for the oral contraceptive pills usage, adverse effects associated with the products, religious issues, and poor availability of the products in underdeveloped regions are major restrains of global oral contraceptive pills market over the forecast years.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/oral-contraceptive-pills-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Oral Contraceptive Pills Market

Oral Contraceptive Pills market is segmented based on the drug type, and distribution channel

Based on the drug type, the market is segmented into the following:

·         Progestin Only Pills

·         Combination Pills

·         Monophasic

·         Triphasic

·         Others

·         Others

Based on the distribution channel, the market is segmented into the following:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/oral-contraceptive-pills-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Oral Contraceptive Pills Market

Geographically, global oral contraceptive pills market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America oral contraceptive pills markethas a lucrative share attributed to high incidence rate of unwanted pregnancies, government support to opt for modern oral contraceptive pills and rise in disposable income. Europe oral contraceptive pills market is poised to grow due to expansion of business by the market players in EU region, grow in women workforce preferring to postpone the pregnancies, and better availability of the products are expected to bolster the market. Asia Pacific oral contraceptive pills market has a lucrative growth attributed to surge in awareness about the family planning and oral contraceptive pills, rise in disposable income, and increase in people opting for right decisions about their sexual and reproductive health are enhance the revenue of market.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/oral-contraceptive-pills-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Oral Contraceptive Pills Market

Some of the players in the global oral contraceptive pills market include:

·         Actavis plc (Allergan plc) (Ireland)

·         Bayer AG (Germany)

·         Merck & Co. Inc. (U.S.)

·         Pfizer, Inc. (U.S.)

·         Teva Pharmaceutical Industries Ltd (Israel)

·         Church & Dwight Co, Inc. (U.S)

·         Mylan N.V. (U.S.)

·         Novartis AG (Switzerland)

·         Piramal Enterprises Limited (India)

Notable Market Developments: Oral Contraceptive Pills Market

·         In April 2018, Mylan N.V. launched Drospirenone and Ethinyl Estradiol tablets in U.S. used as oral contraceptive pills.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/oral-contraceptive-pills-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Nursing Care Services Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 09:15:04 +0200 http://comunicati.net/comunicati/turismo/last_minute/480470.html http://comunicati.net/comunicati/turismo/last_minute/480470.html sravan sravan Nursing Care Services Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Nursing Care Services Market: By Type of Connectivity (Connected to assisted living community, Connected to hospital, Connected to assisted living community and hospital, Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global nursing care services market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Nursing Care Services Market

Nursing care refers to autonomous or collaborative care of individuals of all group, families, communities, by skilled nurses. Nurses are trained to promote the health and prevent various diseases. Trained nurses provide assistance to patients in medical procedures and responsible for giving treatment and medicines. Nursing care approaches of personalized care with more convenience, safety, and comfort.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/nursing-care-services-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Dynamics: Nursing Care Services Market

Increase in number of geriatric population coupled with rise in prevalence of various diseases such as Alzheimer’s disease and dementia are the key factors drive the global nursing care services market. Moreover, rise in persons with disabilities, high disposable income in developed countries, and collaboration between the insurance companies are expected to fuel the nursing care services market over the forecast years. However, high cost of services, low cost of service acceptance in underdeveloped countries, lack of reimbursement services are expected to restrain the growth of global nursing care services market over the forecast period.

 

Market Scope: Nursing Care Services Market

Nursing care services market is segmented on the basis of type of connectivity

Based on the type of connectivity, nursing care services market is segmented into the following:

·         Connected to assisted living community

·         Connected to hospital

·         Connected to assisted living community and hospital

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/nursing-care-services-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Nursing Care Services Market

Geographically, global nursing care services market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America nursing care services market has a lucrative growth attributed to increase in the prevalence of neurodegenerative disorders such as Alzheimer’s and dementia, favorable reimbursement policies, and rise in disposable income are expected to boost the market. Europe nursing care services market has a prominent share attributed to increase in the workforce results to rise in demand for nursing services, rise in number of hospitals, and increase in healthcare expenditure witnessed to propel the market. Asia Pacific nursing care services market is anticipated to offer lucrative opportunities due to increase in geriatric persons in India, China, and Japan, increase in medical tourism in Asia Pacific countries, and increase in the healthcare expenditure in forecast years.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/nursing-care-services-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Nursing Care Services Market

Some of the players in the global nursing care services market include:

·         Genesis Healthcare (U.S.)

·         Lincare Holdings, Inc. (U.S.)

·         Vitas Healthcare (U.S.)

·         Sunrise Senior Living Inc. (U.S.)

·         Apria Healthcare Group Inc. (U.S.)

·         HCR Manor Care, Inc. (U.S.)

·         Kindred Healthcare, Inc. (U.S.)

·         Brookdale Senior Living (U.S.)

·         Extendicare, Inc. (Canada)

·         Golden Living (U.S.)

·         IMMAC Group (Germany)

 

Notable Market Developments: Nursing Care Services Market

·         In December 2017, IMMAC Group acquired Beechfield Care for strengthening of its presence in Europe

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/nursing-care-services-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Nurse Call Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 08:04:50 +0200 http://comunicati.net/comunicati/turismo/localita/milano_marittima/480457.html http://comunicati.net/comunicati/turismo/localita/milano_marittima/480457.html sravan sravan Nurse Call Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Nurse Call Systems Market: By Product Type (Intercom Systems, Button Systems, Integration Communication Systems, Mobile Systems, Others), By Technology (Wired Systems, Wireless Systems), By Application (Emergency Medical Support, Workflow Support, Wanderer Support, Others), By End User (Hospitals, Nursing Homes, Assisted Living Centers, Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global nurse call systems market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024

 

Market Outline: Global Nurse Call Systems Market

Nurse call systems are communication equipment designed to alert the nurse or other healthcare staff in case of medical emergency or when assistance is needed. These are widely used in the healthcare sector for medical emergency and used in assisted living homes and old age centers to give indication when help is required.

 

Market Dynamics: Global Nurse Call Systems Market

Increase in the growth of geriatric population coupled with rise in prevalence of chronic diseases are anticipated to drive the nurse call systems market. Moreover, technological advancements for nurse call systems, development in healthcare infrastructure, diversification of nurse call systems usage in different servicing areas, and increase in installation of nurse call systems by healthcare providers to offer better services are expected to spur nurse call systems market over the forecast years. However, high installation and maintenance cost, stringent regulations to pertain the deployment of nurse call systems in hospitals, and lack of awareness are expected to impede the growth of nurse call systems market over the forecast years.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/nurse-call-systems-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Global Nurse Call Systems Market

Global nurse call systems market is segmented based on product type, technology, application, and end user

Based on product type, market is segmented into the following:

·         Intercom Systems

·         Button Systems

·         Integration Communication Systems

·         Mobile Systems

·         Others

Based on the technology, market is segmented into the following:

·         Wired Systems

·         Wireless Systems

Based on the application, market is segmented into the following:

·         Emergency Medical Support

·         Workflow Support

·         Wanderer Support

·         Others

Based on the end users, the market is segmented into the following:

·         Hospitals

·         Nursing Homes

·         Assisted Living Centers

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/nurse-call-systems-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis: Global Nurse Call Systems Market

Geographically, global nurse call systems market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America nurse call systems market led by U.S., due to government funding to incorporate the advanced technologies in nursing education in U.S., wide area of applications, and increase in geriatric population is expected to fuel the market. Europe nurse call systems market is driven by increase in demand for assisted living centers, high adoption of innovative technologies, and rise in prevalence of chronic diseases. However, Asia pacific nurse call systems market is expected to register fastest growth over the forecast period. Development in the healthcare infrastructure, rise in number of hospitals and nursing centers, and government enhancing the healthcare expenditure for providing the better nursing services are expected to fuel the market.

 

Competition Assessment: Global Nurse Call Systems Market

Some of the players in the global nurse call systems market include:

·         Hill-Rom Holdings, Inc. (U.S.)

·         Honeywell International, Inc. (U.S.)

·         Ascom Holding AG (Switzerland)

·         Rauland-Borg Corporation (U.S.)

·         Tyco SimplexGrinnell (Tyco International PLC) (U.S.)

·         Cornell Communications, Inc. (U.S.)

·         Fresenius SE & Co. KGaA (Germany)

·         Baxter International Inc. (U.S.)

·         Azure Healthcare Ltd. (Australia)

·         Jeron Electronic Systems, Inc. (U.S.)

·         Salient Networks, Inc. (U.S.)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/nurse-call-systems-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Global Nurse Call Systems Market

·         In May 2017, Salient Networks and Responsecare, Inc. launched the RCare BCube wireless nurse call system in U.S.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/nurse-call-systems-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Nurse Call Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 08:04:47 +0200 http://comunicati.net/comunicati/turismo/localita/milano_marittima/480456.html http://comunicati.net/comunicati/turismo/localita/milano_marittima/480456.html sravan sravan Nurse Call Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Nurse Call Systems Market: By Product Type (Intercom Systems, Button Systems, Integration Communication Systems, Mobile Systems, Others), By Technology (Wired Systems, Wireless Systems), By Application (Emergency Medical Support, Workflow Support, Wanderer Support, Others), By End User (Hospitals, Nursing Homes, Assisted Living Centers, Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global nurse call systems market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024

 

Market Outline: Global Nurse Call Systems Market

Nurse call systems are communication equipment designed to alert the nurse or other healthcare staff in case of medical emergency or when assistance is needed. These are widely used in the healthcare sector for medical emergency and used in assisted living homes and old age centers to give indication when help is required.

 

Market Dynamics: Global Nurse Call Systems Market

Increase in the growth of geriatric population coupled with rise in prevalence of chronic diseases are anticipated to drive the nurse call systems market. Moreover, technological advancements for nurse call systems, development in healthcare infrastructure, diversification of nurse call systems usage in different servicing areas, and increase in installation of nurse call systems by healthcare providers to offer better services are expected to spur nurse call systems market over the forecast years. However, high installation and maintenance cost, stringent regulations to pertain the deployment of nurse call systems in hospitals, and lack of awareness are expected to impede the growth of nurse call systems market over the forecast years.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/nurse-call-systems-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Global Nurse Call Systems Market

Global nurse call systems market is segmented based on product type, technology, application, and end user

Based on product type, market is segmented into the following:

·         Intercom Systems

·         Button Systems

·         Integration Communication Systems

·         Mobile Systems

·         Others

Based on the technology, market is segmented into the following:

·         Wired Systems

·         Wireless Systems

Based on the application, market is segmented into the following:

·         Emergency Medical Support

·         Workflow Support

·         Wanderer Support

·         Others

Based on the end users, the market is segmented into the following:

·         Hospitals

·         Nursing Homes

·         Assisted Living Centers

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/nurse-call-systems-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis: Global Nurse Call Systems Market

Geographically, global nurse call systems market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America nurse call systems market led by U.S., due to government funding to incorporate the advanced technologies in nursing education in U.S., wide area of applications, and increase in geriatric population is expected to fuel the market. Europe nurse call systems market is driven by increase in demand for assisted living centers, high adoption of innovative technologies, and rise in prevalence of chronic diseases. However, Asia pacific nurse call systems market is expected to register fastest growth over the forecast period. Development in the healthcare infrastructure, rise in number of hospitals and nursing centers, and government enhancing the healthcare expenditure for providing the better nursing services are expected to fuel the market.

 

Competition Assessment: Global Nurse Call Systems Market

Some of the players in the global nurse call systems market include:

·         Hill-Rom Holdings, Inc. (U.S.)

·         Honeywell International, Inc. (U.S.)

·         Ascom Holding AG (Switzerland)

·         Rauland-Borg Corporation (U.S.)

·         Tyco SimplexGrinnell (Tyco International PLC) (U.S.)

·         Cornell Communications, Inc. (U.S.)

·         Fresenius SE & Co. KGaA (Germany)

·         Baxter International Inc. (U.S.)

·         Azure Healthcare Ltd. (Australia)

·         Jeron Electronic Systems, Inc. (U.S.)

·         Salient Networks, Inc. (U.S.)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/nurse-call-systems-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Global Nurse Call Systems Market

·         In May 2017, Salient Networks and Responsecare, Inc. launched the RCare BCube wireless nurse call system in U.S.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/nurse-call-systems-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Neem Extracts Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 08:04:36 +0200 http://comunicati.net/comunicati/istituzioni/regioni/campania/480455.html http://comunicati.net/comunicati/istituzioni/regioni/campania/480455.html sravan sravan Neem Extracts Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Neem Extracts Market: By Product Type (Seed Extract, Bark Extract, Leaf Extract), By Application (Pharmaceutical, Agriculture, Animal Feed, Cosmetics, Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global neem extracts market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024

 

Market Outline: Global Neem Extracts Market

Neem extracts are derived from neem tree such as leaves, bark, and seeds. Neem extracts have significant medicinal values and used in the pharmaceuticals, agriculture, and agriculture sectors.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/neem-extracts-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Dynamics: Global Neem Extracts Market

Increase in the awareness about the use of natural personal care products is a key factor drives the global neem extracts market. Moreover, rise in adoption of bio-fertilizers in agriculture segment, technological advancements in the neem extract, and increase in R&D for innovation of newer products, and easy availability of raw materials are anticipated to fuel the global neem extracts market. However, demand supply gap for neem extracts, lack of quality raw materials, and high cost of products are expected to hinder the growth of global neem extract market.

 

Market Scope: Global Neem Extracts Market

Global neem extracts market is segmented based on product type and application

Based on the product type, the market is segmented into the following:

·         Seed Extract

·         Bark Extract

·         Leaf Extract

Based on the application, the market is segmented into the following:

·         Pharmaceutical

·         Agriculture

·         Animal Feed

·         Cosmetics

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/neem-extracts-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis: Global Neem Extracts Market

Geographically, global neem extracts market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America neem extracts market is expected to dominated the revenue share owing to increase in the usage of bio-fertilizers, rise in number of end user industries, and government initiations for usage of natural products instead of chemical compounds are expected to propel the market. Due to stringent regulations for the usage of chemical fertilizers in Europe, rise in the usage of personal care and cosmetic products, and increase in the livestock farming is expected to drive Europe neem extracts market. However, Asia Pacific neem extracts market is expanding at robust CAGR owing to better availability of the raw materials, rise in agriculture farming in India and China, and high awareness about the medicinal values of neem extracts are bolster the market.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/neem-extracts-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Global Neem Extracts Market

Some of the players in the global neem extracts market include:

·         Fortune Biotech Ltd (India)

·         Agro Extracts Limited (India)

·         Neeming Australia Pty. Ltd (Australia)

·         Ozone Biotech (India)

·         The Indian Neem Tree Company (India)

·         PJ Margo Pvt. Ltd (India)

·         I.D Perry India Ltd. (India)

·         Parker India Group Pvt. Ltd. (India)

·         Trifolio-M GmbH (Germany)

·         Bros India Group (India)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/neem-extracts-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Non-Sugar Sweeteners Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Wed, 23 May 2018 13:33:39 +0200 http://comunicati.net/comunicati/turismo/manifestazioni/480363.html http://comunicati.net/comunicati/turismo/manifestazioni/480363.html sravan sravan Non-Sugar Sweeteners Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Non-Sugar Sweeteners Market: By Type (Natural Sweeteners and Artificial Sweetener), By Application (Food and Beverages), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global non-sugar sweeteners market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Non-Sugar Sweeteners Market

Non-sugar sweeteners are the food additives that are added in the food and beverages as the alternative to sugar which provides sweet taste. The sugars substitutes that are used in the food and beverages are produced either naturally or produced synthetically. The sugar substitutes that are produced synthetically are called as the artificial sweeteners. The non-sugar sweeteners are typically used in diet and low calorie food and beverages.

 

Increase in the prevalence of obesity and diabetes are the major factors affecting the growth of the non-sugar sweeteners market. The rising awareness among the people regarding the non-sugar sweeteners and their benefits is enriching the growth of the market. The increasing urbanization along with growing health problems and rising demand for the high intensity sweeteners are likely to enhance the growth of the market. However, the high cost of the product may hinder the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/non-sugar-sweeteners-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Non-Sugar Sweeteners Market

Non-sugar sweeteners market is segmented based on the type, and application

Based on the type, the market is segmented into the following:

·         Natural Sweeteners

o    Glycyrrhizin

o    Stevia

o    Sorbitol

o    Monatin

o    Thaumatin

o    Tagatose

o    Others

·         Artificial Sweeteners

o    Alitame

o    Aspartame

o    Neotame

o    Cyclamate

o    Acesulfame Potassium

o    Others

Based on the application, the market is segmented into the following:

·         Food

o    Baked Products

o    Frozen Desserts

o    Others

·         Beverage

o    High-Fructose Corn Syrup

o    Sugar Alcohol

o    Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/non-sugar-sweeteners-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Non-Sugar Sweeteners Market

Geographically, global non-sugar sweeteners market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America non-sugar sweeteners market is dominant when compared with that of the other regions. The rising obese patient pool and diabetic population are the factors responsible for the growth of the market in the region. According to the World Health Organization (WHO) diabetes is forecasted to be the 7th leading cause of death by 2030. The growing health consciousness and rising fitness concerns are also enhancing the growth of the market in the region. Following North America, are the regions of Europe and Asia-Pacific. The emerging countries in the Asia-Pacific region has grown at faster pace. The increasing demand of low calorie diet is expected to drive the growth of the non-sugar sweeteners market in the Asia-Pacific region.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/non-sugar-sweeteners-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Non-Sugar Sweeteners Market

Some of the players in the global non-sugar sweeteners market include:

·         Zydus Wellness Ltd. (India)

·         Cargill (U.S)

·         Tate & Lyle (U.K)

·         Danisco (Denmark)

·         Archer Daniels Midland Company (U.S)

·         Merisant worldwide Inc. (U.S)

·         Imperial Sugar Co (U.S)

 

Notable Market Developments: Non-Sugar Sweeteners Market

·         In June 2017, Zydus Wellness announced national launch of sugar free green

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/non-sugar-sweeteners-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

]]>
Antibody Drug Conjugates Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Wed, 23 May 2018 13:33:27 +0200 http://comunicati.net/comunicati/turismo/manifestazioni/480362.html http://comunicati.net/comunicati/turismo/manifestazioni/480362.html sravan sravan Antibody Drug Conjugates Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Antibody Drug Conjugates Market: By Product Type (Kadcyla, Adcertis, Others), By Application (Leukemia, Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to2024

 

Global antibody drug conjugates market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.

 

Market Outline: Global Antibody Drug Conjugates Market

Antibody drug conjugates (ADCs) are novel targeted therapy drugs for the treatment of cancer. ADCs are composed of monoclonal antibodies attached to biologically active drugs by chemical linkers. They have targeting property of monoclonal antibodies combine with cancer cell killing of cytotoxic drugs. ADCs are examples of immunoconjugates and bioconjugates.

 

Market Dynamics: Global Antibody Drug Conjugates Market

Increase in prevalence of cancer due to change in lifestyle such as consumption of alcohol and tobacco around the globe is a key factor drives the global antibody drug conjugates market. Moreover, rise in R&D for the innovation of newer drugs, pipeline products under the various stages of clinical trials, grow in collaborations between the research institutes for oncology research, and raise in funding from the public and private sectors for R&D are anticipated to fuel the global antibody drug conjugates market. However, stringent regulations for the product approval, less number of existed drugs in the market, and high cost and adverse effects of products are expected to dampen the global antibody drug conjugates market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Global Antibody Drug Conjugates Market

Antibody drug conjugates market is segmented on the basis of product type, application, and distribution channel

Based on the product type, the market is segmented into the following:

·         Kadcyla

·         Adcertis

·         Others

Based on the application, the market is segmented into the following:

·         Leukemia

·         Lymphoma

Based on the distribution channel, the market is segmented into the following:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis: Global Antibody Drug Conjugates Market

Geographically, global antibody drug conjugates market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America antibody drug conjugates market is poised to grow owing to rise in prevalence of various types of cancer, advancements in the newer cancer therapeutics by using nanotechnology, and recent FDA approval for the ADC molecules are anticipated to propel the market. Europe antibody drug conjugates market anticipated to offer lucrative opportunities due to increase in demand for antibody drug conjugate molecules, rise in R&D for the development of newer products, and presence of huge number of contract manufacturing companies. However, Asia Pacific antibody drug conjugates market is poised to grow at highest CAGR due to entry of market players into Asia Pacific countries, government support for the development of newer cancer therapeutics, and pipeline products.

 

Competition Assessment: Global Antibody Drug Conjugates Market

Some of the players in the global antibody drug conjugates market include:

·         Roche Holding AG (Switzerland)

·         Pfizer Inc. (U.S.)

·         Bayer HealthCare (Germany)

·         Progenics Pharmaceuticals (U.S.)

·         Roche Holding AG (Switzerland)

·         ImmunoGen, Inc. (U.S.)

·         Celldex Therapeutics (U.S.)

·         AbbVie Inc. (U.S.)

·         Millennium Pharmaceuticals (U.S.)

·         Agensys, Inc. (U.S.)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Antibody Drug Conjugates Market

·         In September 2017, Pfizer, Inc. received FDA approval for the Mylotarg (Gemtuzumab Ozogamicin), and antibody drug conjugate used in newly diagnosed and relapsed or refractory CD33-Positive acute myeloid leukemia.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

]]>
Antibody Drug Conjugates Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Wed, 23 May 2018 13:33:25 +0200 http://comunicati.net/comunicati/turismo/manifestazioni/480361.html http://comunicati.net/comunicati/turismo/manifestazioni/480361.html sravan sravan Antibody Drug Conjugates Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Antibody Drug Conjugates Market: By Product Type (Kadcyla, Adcertis, Others), By Application (Leukemia, Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to2024

 

Global antibody drug conjugates market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.

 

Market Outline: Global Antibody Drug Conjugates Market

Antibody drug conjugates (ADCs) are novel targeted therapy drugs for the treatment of cancer. ADCs are composed of monoclonal antibodies attached to biologically active drugs by chemical linkers. They have targeting property of monoclonal antibodies combine with cancer cell killing of cytotoxic drugs. ADCs are examples of immunoconjugates and bioconjugates.

 

Market Dynamics: Global Antibody Drug Conjugates Market

Increase in prevalence of cancer due to change in lifestyle such as consumption of alcohol and tobacco around the globe is a key factor drives the global antibody drug conjugates market. Moreover, rise in R&D for the innovation of newer drugs, pipeline products under the various stages of clinical trials, grow in collaborations between the research institutes for oncology research, and raise in funding from the public and private sectors for R&D are anticipated to fuel the global antibody drug conjugates market. However, stringent regulations for the product approval, less number of existed drugs in the market, and high cost and adverse effects of products are expected to dampen the global antibody drug conjugates market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Global Antibody Drug Conjugates Market

Antibody drug conjugates market is segmented on the basis of product type, application, and distribution channel

Based on the product type, the market is segmented into the following:

·         Kadcyla

·         Adcertis

·         Others

Based on the application, the market is segmented into the following:

·         Leukemia

·         Lymphoma

Based on the distribution channel, the market is segmented into the following:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis: Global Antibody Drug Conjugates Market

Geographically, global antibody drug conjugates market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America antibody drug conjugates market is poised to grow owing to rise in prevalence of various types of cancer, advancements in the newer cancer therapeutics by using nanotechnology, and recent FDA approval for the ADC molecules are anticipated to propel the market. Europe antibody drug conjugates market anticipated to offer lucrative opportunities due to increase in demand for antibody drug conjugate molecules, rise in R&D for the development of newer products, and presence of huge number of contract manufacturing companies. However, Asia Pacific antibody drug conjugates market is poised to grow at highest CAGR due to entry of market players into Asia Pacific countries, government support for the development of newer cancer therapeutics, and pipeline products.

 

Competition Assessment: Global Antibody Drug Conjugates Market

Some of the players in the global antibody drug conjugates market include:

·         Roche Holding AG (Switzerland)

·         Pfizer Inc. (U.S.)

·         Bayer HealthCare (Germany)

·         Progenics Pharmaceuticals (U.S.)

·         Roche Holding AG (Switzerland)

·         ImmunoGen, Inc. (U.S.)

·         Celldex Therapeutics (U.S.)

·         AbbVie Inc. (U.S.)

·         Millennium Pharmaceuticals (U.S.)

·         Agensys, Inc. (U.S.)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Antibody Drug Conjugates Market

·         In September 2017, Pfizer, Inc. received FDA approval for the Mylotarg (Gemtuzumab Ozogamicin), and antibody drug conjugate used in newly diagnosed and relapsed or refractory CD33-Positive acute myeloid leukemia.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

]]>
Cervical Cancer Treatment Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Wed, 23 May 2018 13:33:10 +0200 http://comunicati.net/comunicati/turismo/manifestazioni/480360.html http://comunicati.net/comunicati/turismo/manifestazioni/480360.html sravan sravan Cervical Cancer Treatment Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global Cervical Cancer Treatment Market: By Disease Indication (Pre-malignant Lesions, Early Invasive Stage, Advanced Invasive Stage), By Treatment Type (Simple Hysterectomy, Radical Trachelectomy, Cryotherapy, Laser Surgery, Cold Knife Cone Biopsy, Cone Biopsy, LEEP (Loop Electrosurgical Exclusion Procedure), Chemotherapy, Hormone Therapy, Radiation Therapy, Targeted Therapy, Others), By End User (Hospitals, Ambulatory Surgical Centers, Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global cervical cancer treatment market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Cervical Cancer Treatment Market

Cervical cancer is characterized by the growth of abnormal cells in the cervix region. It is most commonly occur in women due to Human Papilloma Virus (HPV) infection. Most common symptoms associated with cervical cancer include pelvic pain, vaginal bleeding, abnormal vaginal discharge, and pain during the sexual intercourse. Cervical cancer can be treated by chemotherapy, radiation therapy, and surgery among others.

 

Market Dynamics: Cervical Cancer Treatment Market

Increase in the prevalence of cervical cancer around the world is mainly drives the global cervical cancer treatment market. Moreover, advancements in the cervical cancer treatment, early stage disease diagnosis, promising pipeline products, and government initiations for increase the cervical cancer treatment awareness are anticipated to fuel global cervical cancer treatment market over the forecast years. However, high cost for cervical cancer treatment, stringent regulatory guidelines for product approval, entry of generics into the market and adverse effects associated with radiation therapy are expected to restrain the growth of global cervical cancer treatment market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/cervical-cancer-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Cervical Cancer Treatment Market

Cervical cancer treatment market is segmented based on the disease indication, treatment type, and end user

Based on the disease indication, the market is segmented into the following:

·         Pre-malignant Lesions

·         Early Invasive Stage

·         Advanced Invasive Stage

Based on the treatment type, the market is segmented into the following:

·         Simple Hysterectomy

·         Radical Trachelectomy

·         Cryotherapy

·         Laser Surgery

·         Cold Knife Cone Biopsy

·         Cone Biopsy

·         LEEP (Loop Electrosurgical Exclusion Procedure)

·         Chemotherapy

·         Hormone Therapy

·         Radiation Therapy

·         Targeted Therapy

·         Others

Based on the end user, the market is segmented into the following:

·         Hospitals

·         Ambulatory Surgical Centers

·         Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/cervical-cancer-treatment-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Cervical Cancer Treatment Market

Geographically, global cervical cancer treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America cervical cancer treatment marketis anticipated to expand at healthy growth rate due to increase in the prevalence of cervical cancer (according to Centers for Disease Control and Prevention 2014, approximately 12,578 women are diagnosed with cervical cancer), technological advancements for early stage disease diagnosis, and increase in R&D expenditure for the innovation of newer products are anticipated to fuel the market. Europe cervical cancer treatment market driven by increase in the prevalence of cervical cancer in Europe (according to WHO Europe, approximately 28,000 women die from cervical cancer every year), expansion of business by market players, and adoption of newer technologies for surgical cancer treatment are expected to boost the market. Asia Pacific cervical cancer treatment market has a lucrative growth attributed to large patient pool, rise in medical tourism in Asia Pacific countries due to low cost of treatment, and entry of market players into Asia Pacific region are expected to bolster the market.

 

Competition Assessment: Cervical Cancer Treatment Market

Some of the players in the global cervical cancer treatment market include:

·         GlaxoSmithKline Plc (UK)

·         Allergan Plc (UK)

·         Eli Lilly and Company (U.S.)

·         Pfizer, Inc. (U.S.)

·         Bristol-Myers Squibb Company (U.S.)

·         Genentech USA (U.S.)

·         Novartis  AG (Switzerland)

·         Hoffmann La Roche Ltd (Switzerland)

·         Biocon Ltd. (India)

·         Hetero Drugs Ltd. (India)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/cervical-cancer-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Cervical Cancer Treatment Market

·         In May 2017, Bristol Myers Squibb and Advaxis entered into a clinical collaboration to evaluate ADXS-DUAL and Opdivo in metastatic cervical cancer.

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/cervical-cancer-treatment-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

 

 

]]>